Top Markets
#1 Siren Siren +35.00%
#2 TDCCP TDCCP +20.44%
#3 aelf aelf +17.29%
#4 DAPPOS DAPPOS +14.71%
#5 Status Status +7.72%
#6 Tutorial Tutorial +7.24%
#7 DeXe DeXe +6.91%
#8 GRVT Token GRVT Token +6.69%
#9 HOME HOME +6.45%
#10 OpenGradient OpenGradient +6.28%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

688076
Rank in Stocks #8443
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company,... Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
Share Price
$3.99
Last synced: 2026-08-28
Market Cap
$1.26B
Change (1 day)
-0.04%
Change (1 year)
-33.48%
Country
CN
Trade Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)

Category

Healthcare
Revenue for Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)
Revenue in Aug 2026 TTM: 0
According to Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH